The Nicotine Debate in Five Charts

The nicotine debate has generated millions of words. But some patterns are clearer in data than in prose. Here are five data narratives—described in text but imagined as charts—that capture the essence of the nicotine landscape more clearly than any article.

Chart 1: The Risk Continuum. On the x-axis, nicotine products arranged from most to least harmful: combustible cigarettes, cigars, waterpipe, heated tobacco, e-cigarettes, nicotine pouches, snus, NRT. On the y-axis, estimated relative risk of premature mortality compared to never-use. Cigarettes: 15–20x risk. Heated tobacco: perhaps 5–10x. E-cigarettes: perhaps 1–3x. Pouches and snus: approximately 1–1.5x. NRT: approximately 1x. The error bars are wide for novel products—the long-term evidence isn't in. But the direction is clear: combustion is the primary driver of risk, and eliminating combustion reduces risk by an estimated 90–95%. The chart captures the central insight of nicotine harm reduction in a single visualization—and the wide error bars capture the uncertainty that makes the debate unresolved.

Chart 2: Smoking Prevalence in Sweden vs. EU Average, 1970–2025. Two lines: Swedish male smoking prevalence declining steeply from 1970, EU male average declining more slowly. By 2025, Sweden is below 5% (the 'smoke-free' threshold); the EU average is around 20%. The chart captures the Swedish experience—the most important evidence for harm reduction—and the three decades during which snus replaced cigarettes among Swedish men while the rest of Europe continued to smoke. The gap between the lines is measured in preventable deaths, and it's wide.

Chart 3: Cigarette Sales in Japan, 2014–2025. A line showing approximately 180 billion cigarettes sold annually in 2014, declining slowly. Then, from 2016, a steep inflection downward—the IQOS effect. By 2025, cigarette sales are below 100 billion, a decline of over 40% in less than a decade. The chart captures the most rapid smoking decline ever recorded in a major market—driven not by policy but by consumer substitution to a non-combustible alternative. The lesson: when a satisfying alternative is available, smokers switch, and they switch fast.

Chart 4: Youth Nicotine Use in the United States, 2011–2025. Three lines: cigarette smoking (declining throughout, reaching historic lows), overall nicotine use (rising sharply 2017–2019 with JUUL and disposables, then declining), and vaping (the driver of the overall nicotine increase). The chart captures the youth dimension of the nicotine transition—the rise of vaping, the decline of smoking, and the net effect on youth nicotine use (higher than pre-vaping, lower than the 2019 peak). The interpretation is contested: is the chart a story of a new epidemic or of a less harmful replacement for smoking?

Chart 5: Global Tobacco Mortality, 2000–2040 (Projected). A line rising from approximately 5 million annual deaths in 2000 to 7 million in 2020 to a projected peak of 8 million around 2030, before slowly declining. The peak is driven by the maturation of the tobacco epidemic in LMICs; the decline is driven by reduced smoking in high-income countries and, eventually, the lagged effect of reduced initiation and increased cessation globally. The chart captures the central tragedy of the nicotine transition: the deaths are still rising, and they will continue to rise for another decade or more before the policies and products that could prevent them have their full effect. The gap between the projected peak and the trajectory that's achievable with accelerated harm reduction is measured in millions of lives.

Five charts, five data narratives. Each one captures a dimension of the nicotine landscape that thousands of words can describe but a single visualization can reveal. The risk continuum, the Swedish experience, the Japanese acceleration, the youth transition, the mortality trajectory. These are not the only charts that matter. But they're the ones that, together, tell the story of where we are, how we got here, and where we might go next.